Lyndra Therapeutics appoints Adam Sayer new CEO and president
Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO. Sayer, who will also ...
FiercePharma14d
Lyndra taps Thermo Fisher to help with research, commercial production of long-acting oral meds
As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...
GlobalData on MSN13d
Lyndra and Thermo Fisher partner for oral therapies
Lyndra secured $101m in Series E financing to advance its pipeline of long-lasting oral therapy products. "Lyndra and Thermo ...
Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO
Lyndra Therapeutics®, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the ...
GEN12d
Lyndra Therapeutics Signs Manufacturing Agreement with Thermo for Long-Acting Oral Therapies
The LYNX technology originated in the Traverso and Langer Laboratories at MIT, with which Lyndra has an exclusive technology ...
Business Wire14d
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced a strategic collaboration with Thermo ...
Contract Pharma14d
Lyndra, Thermo Fisher Partner to Bring Long-Acting Oral Therapies to Market
Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher Scientific Inc., through which Thermo Fisher will provide global clinical ...